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Hypertension prevalence in sub-Saharan Africa (SSA) is high, is rising and has emerged as the most prevalent cardiovascular disease risk 
factor. Research is required to provide evidence-based findings to prioritise hypertension prevention and control. This systematic review 
aims to describe the distribution of and trends in scientific outputs on hypertension prevalence in population-based studies in SSA over the 
last three decades. Relevant English-language articles documenting hypertension prevalence in population-based studies in SSA, published 
between 1 January 1990 and 25 April 2019, were identified through a comprehensive electronic search of MEDLINE. Of the 3 795 citations 
retrieved, 414 fulfilled the inclusion criteria. Scientific outputs increased incrementally per 10-year period: 1990 - 1999: n=32; 2000 - 2009: 
n=65; and 2010 - 2019: n=317. The greatest number of scientific outputs over the 30-year period originated from South Africa (n=81) and 
Nigeria (n=74). Increasing scientific outputs on hypertension prevalence in SSA have not translated into optimal hypertension management, 
which remains inadequate.
S Afr Med J 2019;109(11 Suppl 1):3-7. https://doi.org/10.7196/SAMJ.2019.v109i11b.14183
Knowledge generation via publications on hypertension 
prevalence in population-based studies conducted 
in sub-Saharan Africa over 30 years: 1990 - 2019
N Peer,1,2 PhD; C George,1 PhD; A-P Kengne,1,2 PhD
1 Non-Communicable Diseases Research Unit, South African Medical Research Council, Durban and Cape Town, South Africa 
2 Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
Corresponding author: N Peer (nasheeta.peer@mrc.ac.za)
Globally, hypertension has been on the rise over the past few decades, 
with the number of individuals increasing from 600 million in 1980 
to nearly 1 billion in 2008;[1] by 2025 the total number is estimated to 
increase to 1.56 billion.[2] Hypertension prevalence in ≥25-year-old 
adults worldwide was ~40% in 2008, with higher rates in low-income 
than high-income countries.[3] The greater burden in poorer regions 
is already imparting a profound effect on populations in low- and 
middle-income countries.[3,4] Approximately 80% of the hypertensive 
disease burden occurs in these regions and over half in people aged 
45 - 69 years.[5] 
Despite the high burden imposed by HIV/AIDS, tuberculosis and 
malaria in sub-Saharan Africa (SSA),[6] hypertension has emerged as 
a significant medical and public health problem.[7] Indeed, the highest 
prevalence of hypertension globally is in SSA (46%);[3] a dramatic 
increase from the early 20th century when hypertension was rare in 
the region.[8] Furthermore, unlike high-income countries where mean 
blood pressure (BP) has decreased over the last three decades, it has 
remained stable in Africa or increased in most countries.[9] In the 
latter half of the 20th century, hypertension has emerged as the most 
prevalent cardiovascular disease (CVD) risk factor in the region.[8] 
Hypertension constitutes the foundation of the CVD epidemic 
in the region[10] and is regarded as one of the continent’s greatest 
health challenges after HIV/AIDS.[11] It remains the primary cause 
of significant financial burden, which includes the cost of caring for 
stroke, ischaemic heart disease and congestive cardiac failure related 
to hypertensive heart disease and systolic dysfunction.[12] Notably, 
mortality attributable to hypertension in persons ˂60 years old was 
25% in SSA compared with only 7% in high-income countries.[13] 
There remains an urgent need for African governments, researchers, 
civil society and other stakeholders to highlight and curb the rampant 
hypertension epidemic in SSA. Research plays a significant role in 
highlighting key health problems, such as hypertension, by providing 
the necessary empirical evidence. This is done by the publication 
of their research in peer-reviewed scientific journals. Governments, 
policymakers and other stakeholders are advised to use this evidence 
when determining healthcare priorities and strategies. This is 
particularly true in resource-constrained settings, where maximum use 
with the greatest health benefits needs to be made of limited resources. 
Nevertheless, research efforts are not always directed to regions 
most in need of such measures. Much of the global research tends 
to concentrate in wealthier regions, which leads to the inequitable 
distribution of research efforts. Consequently, populations suffering 
the world’s greatest health problems, particularly in SSA, are often 
overlooked. Therefore, considering the high and rising burden of 
hypertension in SSA, and the need for hypertension research in the 
region, this systematic review aims to describe the distribution of 
and trends in scientific research outputs on hypertension prevalence 
in population-based studies in SSA over the last three decades, from 
1990 to 2019. 
Methods
Sources of information and selection of eligible studies 
This review was conducted using the Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis (PRISMA) framework.[14] 
Relevant articles documenting the prevalence of hypertension in 
population-based studies in SSA, published between 1 Jan uary 1990 
and 25 April 2019, were identified through a comprehensive elec-
tronic search of MEDLINE (via PubMed). English-language stud-
ies were obtained using key words pertaining to the ‘prevalence’ of 
‘hypertension’, ‘blood pressure’, ‘high blood pressure’ and ‘Africa’, 
‘Sub-Saharan Africa’ or the individual names of SSA countries and 
their variants.[15] Medical Subject Headings (MeSH) terms and 
Boolean operators, such as AND/OR/NOT, were used to string 
terms together. 
Studies were excluded if data collection was conducted among 
patients at healthcare facilities or obtained from hospital or 
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clinic records, and if the study was a 
meta-analysis, review or any other form of 
publication that did not include primary 
data. Studies on self-reported prevalence 
of hypertension alone without measured 
BP were excluded. The cut-points used to 
define hypertension were not considered 
an inclusion criterion. 
Data collection, extraction, 
assessment and synthesis
Two authors (NP, CG) conducted the 
literature search and sequentially (titles, 
abstracts and then full texts) screened these 
items for inclusion (Fig. 1). For inclusion 
in this review, a publication had to be an 
original study containing independent data 
obtained from population-based studies, 
documenting the prevalence of hyper-
tension. If the prevalence of hypertension 
was not included in the abstract, but BP, 
hypertension or metabolic syndrome was 
mentioned, the full texts were examined 
for the prevalence of hypertension. In the 
full text, the prevalence of hypertension or 
enough data (number of events and sample 
size) to compute these estimates had to be 
reported for studies to be included in this 
review. Studies were also included if the 
relevant data were reported for the total 
sample or for subgroups such as individuals 
with/without diabetes or overweight/
obesity or HIV infection. Population-
based studies that were conducted in 
sociodemographic subpopulations, such as 
teachers, office workers and taxi drivers, 
were also included. 
Any disagreements regarding the included 
articles were resolved through discussion 
or reviewed by the third author (APK). 
The reasons for excluding studies were 
also recorded. The data extracted from 
selected articles included the year and 
country of publication. These were collated 
chronologically and per 5- and 10-year 
inter vals for the relevant timeframe. Data 
extraction was done by one author (NP), and 
another author (CG) verified the accuracy 
and validity of extracted data. CG rechecked 
the analyses done by NP and ensured that the 
included articles were correctly categorised 
by country and year.
Statistical analyses
Data analyses included simple descriptive 
statistics to determine the prevalence rates 
over time and by country and region.
Results
Overall trends: 1990 - 2019
We retrieved 3 795 citations from our 
searches. Based on the title or abstract, 276 
of the total retrieved citations were eligible 
and 2 978 were not eligible for inclusion. 
Consequently, 541 full-text articles were 
reviewed and, of those, 138 citations met the 
inclusion criteria. Therefore, 414 published 
articles on hypertension prevalence in 
population-based studies were included in 
this review (Fig. 1). 
Publications increased incrementally 
per 10-year period, with 32 publications in 
1990 - 1999 (Suppl. Table 1; http://www.
samj.org.za/public/sup/14183.pdf), 65 in 
2000 - 2009 (Suppl. Table 2; http://www.
samj.org.za/public/sup/14183.pdf) and 317 
in 2010 - 2019 (Suppl. Table 3; http://www.
samj.org.za/public/sup/14183.pdf). This 
illus trated that publications on hyper tension 
prevalence in SSA were almost 5-fold higher 
in 2010 - 2019 than in 2000 - 2009, while 
publications in 2000 - 2009 were double 
those of 1990 - 1999. A similar trend is 
demonstrated per 5-year period between 
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Fig. 1. Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) diagram. 
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Fig. 2. Number of publications on hypertension prevalence in population-based studies in sub-Saharan 
Africa per 5-year interval for the 30-year period 1990 - 2019. 
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1990 and 2019, with sharp increases after 
2010 (Fig. 2). 
The greatest number of publications over 
the 30-year period 1990 - 2019 originated 
from South Africa (SA) (n=81) and Nigeria 
(n=74) (Figs 3 and 4). Other countries with 
≥20 publica tions for the same interval were 
Ghana (n=29), Ethiopia (n=25), Uganda 
(n=24), Cameroon (n=22) and Tanzania 
(n=20).
Trends per 10-year interval: 1990 - 
1999, 2000 - 2009 and 2010 - 2019
For the 10-year period 1990 - 1999, there 
were ˂10 publications per year, with the 
maximum being 8 in 1997 (Suppl. Table 1). 
There were 5 publications in 1996 and 4 each 
in 1991 and 1999. The greatest number of 
publications for this interval emanated from SA 
(n=7), followed by Nigeria (n=4). There were 
4 bi-country publications, all with data from 
Nigeria and Cameroon. Mauritius, Seychelles 
and Tanzania had 3 publications each. 
Of the 65 publications from 2000 to 2009, 
there were ≥10 in 2007 (n=13), 2008 (n=12) 
and 2009 (n=10) (Suppl. Table 2). SA had 
the greatest number of publications (n=16), 
followed by Seychelles (n=8) and Ghana 
(n=7).
In contrast to the 10-year intervals 1990 - 
1999 and 2000 - 2009, publications for 2010 - 
2019 numbered >30 per year, except for 2010 
(n=9), 2011 (n=13) and 2019 (n=1) (Fig. 5; 
Suppl. Table 3). The greatest number of 
publications were in 2017 (n=56), followed 
by 2013 (n=47) and 2016 (n=46). The dearth 
of publications in 2019 was unsurprising, as 
only 4 months of the year were considered 
in this review. 
Unlike the previous two decades, during 
which the greatest number of publications 
originated from SA, publications in 2010 - 
2019 were dominated by Nigeria (n=66) 
(Fig. 6). This was followed by SA (n=58) 
and multi-country articles (n=25) from a 
diverse range of countries that are too many 
to mention. Other countries with ≥20 publi-
cations in 2010 - 2019 were Uganda (n=23), 
Ethiopia (n=22) and Ghana (n=22). 
Discussion 
This review illustrates that scientific research 
outputs on hypertension prevalence in SSA 
have increased dramatically over the past 
three decades, and particularly during the 
past 10 years. From 1990 - 1999 to 2010 - 
2019 the average number of publications per 
year has increased 10-fold from ~3 per year 
in the first 10-year period examined to >30 per 
year in the 2010 - 2019 interval. 
Considering the high hypertension 
prevalence in SSA, this is an important and 
positive finding. The incremental increase 
in publications on hypertension prevalence 
over the past 30 years may possibly reflect 
the rising hypertension burden and thus 
greater awareness of the escalating problem 
in the region. Moreover, the burden of 
hypertension in SSA is much greater; in 
black compared with white populations, 
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Fig. 3. Countries with >10 publications on hypertension prevalence in population-based studies in 
sub-Saharan Africa for the 30-year period 1990 - 2019.
Fig. 4. Map of Africa graphically presenting the number of publications on hypertension prevalence in 
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hypertension occurs at younger ages and BP 
levels are frequently more severely elevated, 
leading to greater target-organ damage.[16] 
However, although there may be greater 
awareness of the hypertension epidemic in 
SSA, this, unfortunately, has not translated 
into concerted efforts to address the problem. 
Levels of hypertension awareness, treatment 
and control remain despairingly low at 27%, 
18% and 7%, respectively.[17] Furthermore, 
healthcare systems in the region are weak, 
with insufficient or non-functioning BP- 
measuring devices, thus preventing simple 
and accurate BP assessment in clinics.[18] This 
highlights the woeful inattention paid to 
hypertension and the inability to manage a 
highly treatable condition. 
Antihypertensive therapy, when optimally 
prescribed, is among the most efficient means 
for disease prevention.[19] Incidences of stroke 
and heart attacks are reduced by 35 - 40% 
and 20 - 25%, respectively.[19,20] Therefore, 
even in SSA, a substantial commitment of 
scarce resources must be considered for the 
management of hypertension, using the total 
CVD risk assessment approach.[19,21]
Furthermore, modifiable risk factors asso-
ciated with hypertension, such as obesity, 
physical inactivity, high salt intake, and 
alcohol and tobacco use, are increasing 
or above the recommended limits in  the 
region.[16] This illustrates inertia among SSA 
policymakers to tackle hypertension and 
other non-communicable diseases at the 
population level. In SSA, where healthcare 
resources are particularly scarce, investment 
in prevention strategies is likely to yield 
the greatest benefit[2] and should be a public 
health priority in the region.[4]
SA and Nigeria have the greatest number 
of publications on hypertension in SSA 
over the past 30 years. The hypertension 
prevalence in SA has almost doubled over 
nearly two decades: nationally, it increased 
from 23% and 25% in ≥15-year-old men 
and women, respectively, in 1998,[22] to 44% 
and 47%, respectively, in 2016.[23] Mirroring 
this increase in hypertension prevalence is 
the rise in the number of publications from 
7 (1990 - 1999) to 58 (2010 - 2019). 
However, a cross-sectional study conduc-
ted in Cape Town, SA, reported an increase 
in hypertension prevalence from 21.6% in 
1990 to 35.6% in 2008/2009 in 25 - 64-year-
old adults, but not an associated improve-
ment in hypertension awareness, treatment 
and control in men.[24] Between 1990 and 
2008/2009, among men with hypertension, 
these rates decreased from 29.2% to 27.1% 
(awareness), 19.2% to 15.6% (treatment) and 
12.6% to 6.4% (control). 
This highlights the need for evidence-
based research to be translated into tangible 
action. SA is generally characterised by good 
policies and strategies, as shown in the 
Department of Health’s Controlling Non-
communicable Diseases through Health System 
Strengthening document.[25,26] However, the 
implementation of these policies needs to 
be prioritised and fast-tracked, and there 
needs to be an equivalent emphasis on 
the monitoring and evaluation of these 
programmes.[25] This can only be achieved 
through improved stewardship, leadership 
and management of the healthcare system.
Hypertension prevalence in Nigeria has 
increased from 11.2% in 1997, based on 
the former definition of hypertension 
(BP  ≥160/95 mmHg), to the current esti-
mate of 28.9%.[27] However, the number of 
individual publications on hypertension were 
4 each in 1990 - 1999 and 2000 - 2009, 
escala ting to 66 in 2010 - 2019. As in SA, the 
increased focus on hypertension in the litera-
ture has not translated to optimal hyperten-
sion management. An opportunistic cross-
sectional survey in 2017 reported a hyperten-
sion prevalence of 36.2%; among those on 
antihypertensive medication, more than half 
(58.8%) had uncontrolled BP despite receiv-
ing treatment.[28] This highlights the need 
to implement rigorous evidence-based mea-
sures to improve hypertension management 
and control. Policymakers in SSA should 
seriously consider the evidence-based data in 
their countries and translate these into best 
practice public health policies. Such evidence 
should be used for planning current and 
future healthcare services, with resources 
allocated appropriately to develop cost-effec-
tive therapeutic strategies and programmes. 
The publications for SA and Nigeria 
between 1990 and 2019 were >2.5-fold 
greater than those for Ghana, which had 
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the third most publications in the region. This may possibly be 
attributed to the strength of their economies; these two countries 
had the highest gross domestic product (GDP) on the continent in 
2018.[29,30] Their individual GDPs were >7-fold greater than Ghana’s 
GDP and much higher than the GDPs of the other countries with 
>10 publications during this period. Interestingly, these countries 
(not Seychelles) were listed in the top 15 SSA countries with the 
highest GDPs. This may reflect these countries’ greater ability in 
terms of infrastructure and resources to support scientific research 
compared with their poorer counterparts. Of note, this is possibly 
also applicable to Seychelles; while the country features near the 
bottom of the list in terms of total GDP, it leads the continent in terms 
of GDP per capita. 
Study limitations
The present study has a few limitations, most of which were beyond 
the scope of this review. Only a single search engine was used, and 
publications were limited to those in the English language. The review 
evaluated the number of publications and not the number of studies; 
therefore, multiple publications from individual studies may have 
been included. The quality of the study designs and the participant 
recruitment techniques were not assessed. Consequently, studies 
were equally weighted irrespective of sample representativeness, i.e. 
random v. convenient sampling, small v. large sample sizes, and wide 
v. narrow age ranges. The quality of BP measurement techniques was 
not appraised, and neither were the definitions of hypertension used 
that would allow for comparability across studies.
Conclusions
Scientific research outputs on hypertension prevalence in SSA have 
increased dramatically between 1990 and 2019, with the greatest 
number of publications over the past 10 years. SA and Nigeria had the 
most publications, followed by those that generally also featured in 
the top 15 countries by GDP in SSA. However, the increased focus on 
hypertension prevalence in the scientific literature has not translated 
into optimal hypertension management and control, which remain 
inadequate in the region. Stakeholders in SSA need to be more vocal 
in holding governments accountable and ensuring that policymakers 
use the available evidence-based research to implement best practice 
solutions to improve healthcare in their countries. The channels 
available to stakeholders for greater government action include 
raising awareness in communities, e.g. via health awareness drives or 
free BP screenings, as conducted by the Heart and Stroke Foundation 
South Africa, and persuading the media to frequently shine the 
spotlight on hypertension. Such measures, with a constant focus on 
hypertension, may pressurise governments to act. 
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Supplementary Table 1. Distribution of publications on hypertension prevalence in population-based studies conducted in  
sub-Saharan Africa: 1990 - 1999
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 Total
Central Africa, n            
Cameroon - - - - - - - - 1 - 1
Western Africa, n            
Gambia - - - - -  - 1 - - 1
Nigeria - - - - - - 1 2 - 1 4
Senegal - - 1 - - - - - - - 1
Sierra Leone - - - - - - - - 1 1 2
Eastern Africa, n           
Ethiopia - - - - - - - 1 - - 1
Mauritius - 1 - - 1 1 - - - - 3
Seychelles - 2 - - - - - - 1 - 3
Tanzania - 1 - 1 - - - 1 - - 3
Southern Africa, n            
Lesotho - - - - 1 - - - - - 1
South Africa 1 - - - - 1 2 2 - 1 7
Zimbabwe - - - 1 - - - - - - 1
Multi-country studies - - - - - - 2 1 - 1 4
Total, n 1 4 1 2 2 2 5 8 3 4 32
Supplementary Table 2. Distribution of publications on hypertension prevalence in population-based studies conducted in  
sub-Saharan Africa: 2000 - 2009
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total
Central Africa, n            
Angola - - - - - - - - - -  -
Cameroon - 2 1 1 - - - 2 - - 6
Democratic Republic of Congo - - - - - - - - 2 1 3
Western Africa, n          
Benin - - - - - - -  1 1 2
Burkina Faso - - - - - - - 1 - - 1
Gambia 1 - - - - - - - - - 1
Ghana - - - 1 - - 3 2 - 1 7
Guinea - - - - - - - 1 - - 1
Nigeria - 1 1 - - - - 1 1 - 4
Eastern Africa, n            
Ethiopia - - - - - - - 1 - 1 2
Eritrea - - - - - - 2 - - - 2
Madagascar - - - 1 - - - - - - 1
Mauritius 1 - - - - - - - - - 1
Seychelles 1 - 1  1 - 1 1 2 1 8
Tanzania 1 2 - 2 - - - - - - 5
Uganda - - - - - - - - - 1 1
Southern Africa, n            
Botswana - - - - - 1 - - - - 1
Mozambique - - - - - - - - - 1 1
South Africa - 2 - - - 1 - 4 6 3 16
Zimbabwe 2 - - - - - - - - - 2
Multi-country studies  - - - - - - - - - - - 
Total, n 6 7 3 5 1 2 6 13 12 10 65
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Supplementary Table 3. Distribution of publications on hypertension prevalence in population-based studies conducted in  
sub-Saharan Africa: 2010 - 2019
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Total
Central Africa, n            
Angola - - - 3 - - 1 2 - - 6
Cameroon 1 1 1 - 1 5 1 2 3 - 15
Democratic Republic of Congo - - 1 - - 1 - 3 - - 5
Gabon - - 1 - - - - - - - 1
Western Africa, n            
Benin - - 1 1 - 1 - 1 1 - 5
Burkina Faso - - 1 - 2 - - 1 - - 4
Ghana - 1 2 2 4 2 4 3 4 - 22
Guinea - - - - - - 1 - - 1 2
Nigeria 3 3 5 16 2 9 13 9 6 - 66
Senegal - - 3 2 3 - 2 1 - - 11
Togo - - 1 - - - - - - - 1
Eastern Africa, n            
Comoros Archipelago - 1 - - - - - - - - 1
Ethiopia 1 1 2 - 5 2 1 6 4 - 22
Kenya 1 1 1 3 2 1 4 2 3 - 18
Madagascar - - - - - 1 - - 1 - 2
Malawi - 1 - 1 - - - - 1 - 3
Mauritius - - 1 - - - - - - - 1
Rwanda - - - - - - - 1 - - 1
Seychelles - 1 1 1 - - - 1 - - 4
Somaliland - - - - - 1 - - - - 1
Tanzania 1 - 1 1 1 - 4 3 1 - 12
Uganda - 2 2 5 1 5 4 3 1 - 23
Southern Africa, n            
Mozambique - - - 2 - - - - - - 2
Namibia - - 1 - - 1 - - 1 - 3
South Africa 1 1 4 7 8 7 8 14 8 - 58
Zambia - - - 1 - 1 - - 1 - 3
Multi-country studies 1 - 2 2 3 7 3 4 3 - 25
Total, n 9 13 31 47 32 44 46 56 38 1 317
